Inventaire - your friends and communities are your best library

Commentary on tumor heterogeneity

published in: Translational lung cancer research

date of publication: 2016-08-01

Cites articles 18

Date

Title

Authors

2016-08-01

Rebuttal from Dr. Hofman and Dr. Ilié.

Marius Ilié, Paul Hofman
2016-08-01

Rebuttal from Dr. Mino-Kenudson

Mari Mino-Kenudson
2016-08-01

Pros: Can tissue biopsy be replaced by liquid biopsy?

Marius Ilié, Paul Hofman
2016-08-01

Cons: Can liquid biopsy replace tissue biopsy?-the US experience

Mari Mino-Kenudson
2016-03-01

Progression and metastasis of lung cancer
2016-01-18

Genetic heterogeneity of actionable genes between primary and metastatic tumor in lung adenocarcinoma

Yoon Soo Chang
2015-09-28

Intratumoral Heterogeneity of ALK-Rearranged and ALK/EGFR Coaltered Lung Adenocarcinoma

Fred R Hirsch
2015-09-04

Mutation status concordance between primary lesions and metastatic sites of advanced non-small-cell lung cancer and the impact of mutation testing methodologies: a literature review

James Sherwood
2015-09-01

Molecular profiling of lung adenosquamous carcinoma: hybrid or genuine type?

Matthias Dettmer
2015-05-12

High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets

Raphael Saffroy, Julien Mazieres, Denis Moro-Sibilot, Marie Wislez
2014-10-01

Spatial and temporal diversity in genomic instability processes defines lung cancer evolution

Marco Gerlinger, Zoltan Szallasi, Richard Mitter, Stuart Horswell, Nicholas McGranahan, Ignacio Varela, David C. Wedge, Peter Van Loo, Siow-Ming Lee, Robert C. Rintoul, Charles Swanton, Sharmin Begum, Thierry Voet, David R. Jones, Andrew Rowan, Benjamin Phillimore, Max Salm, Peter J Campbell, Sam M Janes, Gordon Stamp, Mariam Jamal-Hanjani, Seema Shafi, Tanya Ahmad, Mary Falzon, Aengus Stewart, Elza C de Bruin, Nirupa Murugaesu, Bradley Spencer-Dene
2014-02-01

Assessment of intratumoral heterogeneity of oncogenic driver mutations in surgically-resected lung adenocarcinoma: implications of percutaneous biopsy-based molecular assay for target-directed therapy
2014-10-01

Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing

David C. Wedge, Latasha Little, P. Andrew Futreal, Sahil Seth, Ignacio I Wistuba, John V Heymach, Stephen Swisher, Jianhua Zhang, Waun Ki Hong
2011-03-23

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

Mari Mino-Kenudson, Scott Gettinger, Lecia V Sequist, Kristin Bergethon, Dora Dias-Santagata, A John Iafrate, Arjola K Cosper, Jeffrey A Engelman
2010-09-02

Comparison of p53 and epidermal growth factor receptor gene status between primary tumors and lymph node metastases in non-small cell lung cancers

Yih-leong Chang, Chen-Tu Wu, Yung-Chie Lee, Jin-Yuan Shih
2009-12-09

Erlotinib resistance in mouse models of epidermal growth factor receptor-induced lung adenocarcinoma

Harold E. Varmus, Katerina Politi
2009-07-01

Discordance of molecular biomarkers associated with epidermal growth factor receptor pathway between primary tumors and lymph node metastasis in non-small cell lung cancer.

Pasi A Jänne
2006-08-01

Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer.

Katsuyuki Kiura

Article - wd:Q42398711

Welcome to Inventaire

the library of your friends and communities

learn more